UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
APRIL 4, 2005
------------------------------------------------
Date of Report (Date of earliest event reported)
GENOMED, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Florida 000-49720 43-1916702
---------------------------- ----------------------- -------------------
(State or other jurisdiction (Commission File Number (IRS Employer
of incorporation) Identification No.)
9666 OLIVE BOULEVARD, SUITE 300, ST. LOUIS, MISSOURI 63132
----------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(314) 983-9933
----------------------------------------------------
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01 OTHER EVENTS.
On March 31, 2005, GenoMed, Inc. (the "Company") issued a press release
reporting that the Company had become aware of activity over the Internet and
unsolicited electronic mail that encouraged the purchase of the Company's stock.
The Company also reported that it is not responsible for, and is unaware of the
source of such Internet and electronic mail activity. A copy of this press
release is attached hereto as Exhibit 99.1.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
The following exhibits are being furnished as part of this Form 8-K:
EXHIBIT NUMBER DESCRIPTION
99.1 Press release of GenoMed, Inc. dated March 31, 2005.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
GENOMED, INC.
Date: April 4, 2005 By: /s/ Robyn Owens
-----------------------------
Robyn Owens
Chief Financial Officer